Subject to final due diligence, and Board of Director and shareholder ratification, Vega-Atlantic is to merge with Transax, meaning that Transax will become a wholly-owned subsidiary of the Company.
The Company’s business operations will then become the development, acquisition and marketing of leading information network solutions for healthcare providers and health insurance companies and other end-users worldwide.
The Company plans to change its name to Transax International Limited.
Transax is the holding company of TDS Telecommunications Data Systems Ltda. (being renamed Transax Brazil Ltda). Through a licensing agreement from Transax, TDS uses the proprietary software MedLink to provide solutions for healthcare insurance processing.
The company employs approximately 40 staff and contract personnel in Brazil, its entry market.It is anticipated that the Merger Agreement will become effective and the acquisition of Transax will be consummated by approximately August 15, 2003 or as promptly as practicable after approval by the shareholders of Transax of the Merger Agreement.
In accordance with the terms and conditions of the proposed Merger, the Company is expected to issue 11,066,207 shares of its restricted Common Stock, 4,500,000 stock options and 4,100,000 share purchase warrants.
The strategic focus of Transax is to become a premier international provider of information network solutions for healthcare providers and health insurance companies, enabling the real-time automation of routine patient eligibility verifications, authorization, claims processing and payment functions that are currently performed manually.
Online Dragon Pharma Steroids
Dragon Pharma is specialized in the manufacturing of high quality steroid medication Buy Suspension 100.